Apixaban after hip or knee arthroplasty versus enoxaparin: efficacy and safety in key clinical subgroups

Volume: 11, Issue: 3, Pages: 444 - 451
Published: Mar 1, 2013
Abstract
New oral anticoagulants for thromboprophylaxis after hip or knee arthroplasty have been given as fixed-dose regimens.To evaluate the consistency of the antithrombotic efficacy and bleeding risk of apixaban 2.5 mg twice daily compared with enoxaparin 40 mg once daily after knee or hip arthroplasty across the clinical characteristics of age, gender, body weight, body mass index (BMI) and creatinine clearance.The pooled results of the ADVANCE-2...
Paper Details
Title
Apixaban after hip or knee arthroplasty versus enoxaparin: efficacy and safety in key clinical subgroups
Published Date
Mar 1, 2013
Volume
11
Issue
3
Pages
444 - 451
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.